Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Paper Alert: Zebrafish Say TDP-43 Causes ALS by Loss of Function
4 March 2013. Zebrafish embryos with muscle decay and a vasculature in disarray suggest that mutations in TDP-43 contribute to amyotrophic lateral sclerosis and frontotemporal dementia by messing with the protein’s normal function. Bettina Schmid and Christian Haass of the German Center of Neurodegenerative Diseases report in this week’s Proceedings of the National Academy of Sciences online that knocking out the zebrafish orthologues of TDP-43 damages organ systems, rendering the embryos not viable. “Our findings not only reveal an unexpected requirement of TDP-43 for muscle maintenance, blood flow, blood vessel formation, and motor neuron axon outgrowth, but may also provide fresh evidence for a loss-of-function disease mechanism in TDP-43 proteinopathies,” the authors conclude.

Alzforum previously reported Schmid and Haass’ meeting presentations, in which they reported that they only achieved a mutant phenotype when they eliminated both fish versions of the gene, TARDBP and “TARDBP-like.” Double-mutant embryos survive for just a week (see ARF related news story; ARF news story). Human TDP-43 rescues the TARDBP-deficient fish, but Schmid and Haass now add that an ALS-linked mutation, glycine-348-cysteine, saves some knockout embryos. This indicates that while a total loss of TARDBP is indeed lethal, a mild mutation can support life for a short time. “We therefore hypothesize that a subtle loss of function … leads over time to ALS and FTLD-TDP pathology,” the authors suggest.

In the paper, the team added an analysis of the proteome created by TARDBP loss. Thirteen proteins were upregulated and 28 downregulated in the double knockouts. Most of the latter were muscle based, fitting with that phenotype. The top upregulated hit was the muscle protein filamin C, with doubled levels in the knockouts. Human filamin C was upregulated in brains from people with FTLD due to TDP-43 proteinopathy, but not Alzheimer’s or neurologically healthy samples.

Filamin C crosslinks actin in multiple types of muscle, including those surrounding blood vessels in the brain. The authors hypothesize that in cases of TDP-43 proteinopathy, an excess of filamin C diminishes blood flow in the brain, and results in the leaky blood-brain barrier and blood-spinal cord barrier observed in people with ALS (Winkler et al., 2012; Ishikawa et al., 2007).—Amber Dance.

Reference:
Schmid B, Hruscha A, Hogl S, Banzhaf-Strathmann J, Strecker K, van der Zee J, Teucke M, Eimer S, Hegermann J, Kittelmann M, Kremmer E, Cruts M, Solchenberger B, Hasenkamp L, van Bebber F, Van Broeckhoven C, Edbauer D, Lichtenthaler SF, Haass C. Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc Natl Acad Sci U S A. 2013 Mar 1. Abstract

 
Comments on News and Primary Papers
  Comment by:  Tennore Ramesh
Submitted 7 March 2013  |  Permalink Posted 7 March 2013

A recent paper in Human Molecular Genetics also observed that TARDBPl compensates for the loss of TARDBP.

References:
Hewamadduma CA, Grierson AJ, Ma TP, Pan L, Moens CB, Ingham PW, Ramesh T, Shaw PJ. Tardbpl splicing rescues motor neuron and axonal development in a mutant tardbp zebrafish. Hum Mol Genet. 2013 Mar 3. Abstract

View all comments by Tennore Ramesh
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad